Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jannis E Meents

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Molecular Medicine|March 30, 2010
TRPV1 in migraine pathophysiologyJannis E Meents, Lars Neeb, Uwe Reuter
Journal of Neurophysiology|November 29, 2018
TRPA1: a molecular viewJannis E Meents, Cosmin I Ciotu, Michael J M Fischer
The Journal of Physiology|June 17, 2016
Agonist-induced sensitisation of the irritant receptor ion channel TRPA1Jannis E Meents, Michael J M Fischer, Peter A McNaughton
Plos One|January 12, 2017
Sensitization of TRPA1 by Protein Kinase AJannis E Meents, Michael J M Fischer, Peter A McNaughton
The Journal of Biological Chemistry|December 28, 2020
Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivityClara M Kerth, Petra Hautvast, Jannis Körner, et al.
The Journal of Biological Chemistry|September 4, 2021
Correction: Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivityClara M Kerth, Petra Hautvast, Jannis Körner, et al.
British Journal of Pharmacology|May 4, 2018
The opioid oxycodone use-dependently inhibits the cardiac sodium channel Na<sub>V</sub> 1.5Jannis E Meents, Krisztina Juhasz, Sonja Stölzle-Feix, et al.
The Journal of Headache and Pain|June 26, 2015
Two TRPV1 receptor antagonists are effective in two different experimental models of migraineJannis E Meents, Jan Hoffmann, Sandra R Chaplan, et al.
Pflugers Archiv : European Journal of Physiology|August 13, 2018
Loss-of-function of Nav1.8/D1639N linked to human pain can be rescued by lidocaineLuisa Kaluza, Jannis E Meents, Martin Hampl, et al.
Neuropharmacology|August 29, 2019
Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptorsAstrid S Obrecht, Nicole Urban, Michael Schaefer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Molecular Medicine|March 30, 2010
TRPV1 in migraine pathophysiologyJannis E Meents, Lars Neeb, Uwe Reuter
Journal of Neurophysiology|November 29, 2018
TRPA1: a molecular viewJannis E Meents, Cosmin I Ciotu, Michael J M Fischer
The Journal of Physiology|June 17, 2016
Agonist-induced sensitisation of the irritant receptor ion channel TRPA1Jannis E Meents, Michael J M Fischer, Peter A McNaughton
Plos One|January 12, 2017
Sensitization of TRPA1 by Protein Kinase AJannis E Meents, Michael J M Fischer, Peter A McNaughton
The Journal of Biological Chemistry|December 28, 2020
Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivityClara M Kerth, Petra Hautvast, Jannis Körner, et al.
The Journal of Biological Chemistry|September 4, 2021
Correction: Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivityClara M Kerth, Petra Hautvast, Jannis Körner, et al.
British Journal of Pharmacology|May 4, 2018
The opioid oxycodone use-dependently inhibits the cardiac sodium channel Na<sub>V</sub> 1.5Jannis E Meents, Krisztina Juhasz, Sonja Stölzle-Feix, et al.
The Journal of Headache and Pain|June 26, 2015
Two TRPV1 receptor antagonists are effective in two different experimental models of migraineJannis E Meents, Jan Hoffmann, Sandra R Chaplan, et al.
Pflugers Archiv : European Journal of Physiology|August 13, 2018
Loss-of-function of Nav1.8/D1639N linked to human pain can be rescued by lidocaineLuisa Kaluza, Jannis E Meents, Martin Hampl, et al.
Neuropharmacology|August 29, 2019
Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptorsAstrid S Obrecht, Nicole Urban, Michael Schaefer, et al.
Pageof 2